Music |
Video |
Movies |
Chart |
Show |
8 in 8: Update on Immunotherapy for Resectable Lung Cancer (ThoracicSurgeons) View | |
8 in 8 Series: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC (ThoracicSurgeons) View | |
8 in 8 Series: Neoadjuvant Biomarker Trials in Lung Cancer (ThoracicSurgeons) View | |
NSCLC trial updates at ESMO 2022: ADAURA, DESTINY-Lung02, KN189, KN407 u0026 POSEIDON (VJOncology) View | |
Lung cancer: Clinical insights into key research | Gilberto Lopes (Medicine Matters oncology) View | |
Lung Cancer (Part 1): 2021 Comprehensive Updates (Stanley Kim) View | |
An update from ASCO 2018 on targeted therapies in lung cancer | Ross Camidge (Medicine Matters oncology) View | |
Post ESMO Update on IMPower Clinical Trial in Early Stage NSCLC (OMNIConnect) View | |
Chemo +/- Immunotherapy for Mesothelioma-Leading Developments u0026 Current Questions in Lung Cancer (GRACE - Global Resource for Advancing Cancer Education) View | |
The Surgeon’s Role in Managing Patients with Resectable NSCLC (ThoracicSurgeons) View |